Striatal monoamines and reserpine and chlorpromazine rigidity
- 31 December 1976
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology
- Vol. 2 (1) , 113-128
- https://doi.org/10.1016/0306-039x(76)90024-6
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the ratBiochemical Pharmacology, 1972
- Striatal and spinal lesions eliminating reserpine and physostigmine rigidityLife Sciences, 1967
- Evidence for dopamine receptor stimulation by apomorphineJournal of Pharmacy and Pharmacology, 1967
- Functional Role of the Nigro‐Neostriatal Dopamine Neurons*)Acta Pharmacologica et Toxicologica, 1966
- Reciprocal Effects on α‐ and γ‐Motoneurones of Drugs Influencing Monoaminergic and Gholinergic TransmissionActa Physiologica Scandinavica, 1966
- Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neuronsLife Sciences, 1966
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964
- Zur Biochemie des Parkinson-Syndroms des MenschenKlinische Wochenschrift, 1963
- Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-SyndromKlinische Wochenschrift, 1961